DOI: 10.1055/s-00000020

Geburtshilfe und Frauenheilkunde

References

Park YH, Kim TY, Kim GM. et al.
A randomized phase II study of palbociclib plus exemestane with GNRH agonist versus capecitabine in premenopausal women with hormone receptor-positive metastatic breast cancer (KCSG-BR 15–10, NCT02592746).

J Clin Oncol 2019;
37 (Suppl.) Abstr.. 1007

Download Bibliographical Data

Search in: